Ionis Pharmaceuticals | IONS - 销售收入



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 350.07M
销售成本
USD 2.74M
流动资产
USD 2.49B
流动负债
USD 315.64M
债务
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
员工
1.07K
EPS每股收益
USD -0.69
股本和储备
USD 439.74M
销售毛利
USD 265M
债务利息支出
USD 18M
利息收入
USD -0.66
贷款资金
USD 1.91B
市值
USD 9.2B
净收入
USD -114.65M
营业费用
USD 370.24M
营业利润
USD -102.29M
普通股股本
USD 165.64M
PE价格收益
396.15
税前利润
USD -114M
销售收入
USD 268M
销售和管理费用
USD 130.08M
股票
USD 50.83M
贸易债权人
USD 47.7M
应收帐款人
USD 58.85M


销售 更改 日
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Arrowhead Research USD 75.23M 1.49M 2026-06
Astellas Pharma JPY 640.91B 102.98B 2026-06
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
Celltrion KRW 1.24T 90B 2026-06
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Deva Holding AS TRY 2.32B 418.58M 2023-09
Divis Laboratories Ltd INR 27.58B 730M 2026-06
Exelixis USD 628.69M 17.89M 2026-06
Halozyme Therapeutics USD 481M 104M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Kangmei Pharma CNY 1.08B 288.27M 2026-03
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Moderna USD 100M 289M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Neurocrine Biosciences USD 959M 148M 2026-06
Novartis USD 14.41B 1.3B 2026-06
OPKO Health USD 124.2M 24.25M 2026-03
Organigram Holdings CAD 59.79M 3.74M 2026-03
Pfizer USD 15.03B 530M 2026-06
Pharma Mar EUR 50M 7.1M 2026-06
PTC Therapeutics USD 361M 88M 2026-06
Qiagen NV USD 463.12M 43.9M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Sartorius EUR 911.8M 12.7M 2026-06
Sino Biopharmaceutical CNY 19.44B 5.18B 2026-06
Tilray USD 217.51M 74.75M 2025-12
Ultragenyx Pharmaceutical USD 214M 78M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06
Zealand Pharma A/S 34M 34.92M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03